Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 310

1.

Towards liver-directed gene therapy for Crigler-Najjar syndrome.

Miranda PS, Bosma PJ.

Curr Gene Ther. 2009 Apr;9(2):72-82. Review.

PMID:
19355865
3.

Gunn rat: a model for inherited deficiency of bilirubin glucuronidation.

Chowdhury JR, Kondapalli R, Chowdhury NR.

Adv Vet Sci Comp Med. 1993;37:149-73. Review.

PMID:
8273513
4.

Critical assessment of lifelong phenotype correction in hyperbilirubinemic Gunn rats after retroviral mediated gene transfer.

Nguyen TH, Aubert D, Bellodi-Privato M, Flageul M, Pichard V, Jaidane-Abdelghani Z, Myara A, Ferry N.

Gene Ther. 2007 Sep;14(17):1270-7. Epub 2007 Jul 5.

PMID:
17611583
5.

Successful gene therapy of the Gunn rat by in vivo neonatal hepatic gene transfer using murine oncoretroviral vectors.

Bellodi-Privato M, Aubert D, Pichard V, Myara A, Trivin F, Ferry N.

Hepatology. 2005 Aug;42(2):431-8.

PMID:
16025517
6.

Ezetimibe: A biomarker for efficacy of liver directed UGT1A1 gene therapy for inherited hyperbilirubinemia.

Montenegro-Miranda PS, Sneitz N, de Waart DR, Ten Bloemendaal L, Duijst S, de Knegt RJ, Beuers U, Finel M, Bosma PJ.

Biochim Biophys Acta. 2012 Aug;1822(8):1223-9. doi: 10.1016/j.bbadis.2012.04.013. Epub 2012 Apr 21.

7.

Therapeutic lentivirus-mediated neonatal in vivo gene therapy in hyperbilirubinemic Gunn rats.

Nguyen TH, Bellodi-Privato M, Aubert D, Pichard V, Myara A, Trono D, Ferry N.

Mol Ther. 2005 Nov;12(5):852-9. Epub 2005 Sep 2.

8.

Correction of congenital indirect hyperbilirubinemia by small intestinal transplantation.

Medley MM, Hooker RL, Rabinowitz S, Holton R, Jaffe BM.

Am J Surg. 1995 Jan;169(1):20-7.

PMID:
7817994
9.

Correction of hyperbilirubinemia in gunn rats using clinically relevant low doses of helper-dependent adenoviral vectors.

Dimmock D, Brunetti-Pierri N, Palmer DJ, Beaudet AL, Ng P.

Hum Gene Ther. 2011 Apr;22(4):483-8. doi: 10.1089/hum.2010.167. Epub 2011 Feb 16.

10.

Cell transplantation in liver-directed gene therapy.

Raper SE, Wilson JM.

Cell Transplant. 1993 Sep-Oct;2(5):381-400; discussion 407-10. Review.

PMID:
8162279
11.

Genetic lesions of bilirubin uridine-diphosphoglucuronate glucuronosyltransferase (UGT1A1) causing Crigler-Najjar and Gilbert syndromes: correlation of genotype to phenotype.

Kadakol A, Ghosh SS, Sappal BS, Sharma G, Chowdhury JR, Chowdhury NR.

Hum Mutat. 2000 Oct;16(4):297-306. Review.

PMID:
11013440
13.

A novel strategy for in vivo expansion of transplanted hepatocytes using preparative hepatic irradiation and FasL-induced hepatocellular apoptosis.

Takahashi M, Deb NJ, Kawashita Y, Lee SW, Furgueil J, Okuyama T, Roy-Chowdhury N, Vikram B, Roy-Chowdhury J, Guha C.

Gene Ther. 2003 Feb;10(4):304-13.

PMID:
12595889
14.

Gene replacement therapy for genetic hepatocellular jaundice.

van Dijk R, Beuers U, Bosma PJ.

Clin Rev Allergy Immunol. 2015 Jun;48(2-3):243-53. doi: 10.1007/s12016-014-8454-7. Review.

PMID:
25315738
15.

Nonviral gene transfer into liver and muscle for treatment of hyperbilirubinemia in the gunn rat.

Dankó I, Jia Z, Zhang G.

Hum Gene Ther. 2004 Dec;15(12):1279-86.

PMID:
15684703
17.

Long-term reduction of serum bilirubin levels in Gunn rats by retroviral gene transfer in vivo.

Tada K, Chowdhury NR, Neufeld D, Bosma PJ, Heard M, Prasad VR, Chowdhury JR.

Liver Transpl Surg. 1998 Jan;4(1):78-88.

18.

[Correction of bilirubin glucuronyl transferase in Gunn rats by gene transfer in the liver using retroviral vectors].

Branchereau S, Ferry N, Myara A, Sato H, Kowai O, Trivin F, Houssin D, Danos O, Heard J.

Chirurgie. 1993-1994;119(10):642-8. French.

PMID:
7729182
20.

Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar syndrome type 1.

Li Q, Murphree SS, Willer SS, Bolli R, French BA.

Hum Gene Ther. 1998 Mar 1;9(4):497-505.

PMID:
9525311

Supplemental Content

Support Center